Literature DB >> 7340892

Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food.

S Pedersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7340892      PMCID： PMC1401935          DOI： 10.1111/j.1365-2125.1981.tb01329.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Influence of diet and fluid on bioavailability of theophylline.

Authors:  P G Welling; L L Lyons; W A Craig; G A Trochta
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

2.  Comparison of three assay procedures for theophylline determination.

Authors:  I S Kampa; L K Dunikoski; J I Jarzabek; D Grubesich
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

3.  Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.

Authors:  C J Russell; R K Elwood; C Kinney; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953
  3 in total
  12 in total

1.  The influence of food on the bioavailability of a slow release theophylline preparation.

Authors:  J J Thebault; J M Aiache; F Mazoyer; J M Cardot
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 2.  The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-10-01

Review 3.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

4.  Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

5.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.

Authors:  M Lagas; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  The effect of food on the absorption of controlled-release theophylline in mini-swine.

Authors:  G K Shiu; A O Sager; R B Velagapudi; V K Prasad; J P Skelly
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

8.  The influence of antacid on the absorption of two different sustained-release formulations of theophylline.

Authors:  K I Myhre; R A Walstad
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

9.  Treatment of children with a single dose a day of sustained release theophylline.

Authors:  S Pedersen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

10.  The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.

Authors:  J C Mucklow; S Kuhn
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.